Latest Articles

Communication award for Auckland scientist

29 November 2012

The New Zealand Association of Scientists has this week awarded the Science Communicators Award for 2012 to Dr Siouxsie Wiles from The University of Auckland and Maurice Wilkins Ce

read more

Centre celebrates national research honours

21 November 2012

The Maurice Wilkins Centre is delighted that four of its investigators – Professors Margaret Brimble, John Fraser and David Williams and Dr Richard Furneaux – received prestigious

read more

Secondary school book award for principal investigator

16 November 2012

Maurice Wilkins Centre principal investigator Professor Peter Shepherd and co-author Rachel Heeney, Head of Biology at Epsom Girls Grammar School, won the Best Book or Series in Se

read more

Image-conscious researchers to meet at symposium

12 November 2012

New Zealand technologies being developed to more accurately deliver anticancer drugs, locate the sites where drugs are “switched on”, and to model the skin over a person’s entire b

read more

Science day for secondary school teachers

8 November 2012

Auckland secondary school teachers yesterday received an intensive update on the latest in biomedical science at an event sponsored by the Maurice Wilkins Centre.

read more

Promising New Zealand compound selected as drug candidate for tuberculosis

17 September 2012

A New Zealand-designed compound that shows promise against treatment-resistance tuberculosis (TB) has been selected as a drug candidate by international non-profit drug developer t

read more

Centre hosts Chinese regional leaders

Centre hosts Chinese regional leaders

13 September 2012

Regional leaders from Zhejiang province yesterday visited the Maurice Wilkins Centre for Molecular Biodiscovery, to continue developing scientific links between China and New Zeala

read more

Local cancer drug approved for first clinical trial in United States and New Zealand

30 August 2012

The US Food and Drug Administration (FDA) has granted approval for PR610, an anticancer “stealth” drug invented in New Zealand, to move forward to human clinical trials through its

read more